Doug Brownstone is an accomplished executive with extensive experience in digital marketing, innovation, and general management. He has worked with reputable Consumer and Healthcare companies such as Procter & Gamble, Johnson & Johnson, Novartis, Samsung, and GlaxoSmithKline. Brownstone is a distinguished graduate of Cornell University and holds a Master of Business Administration (M.B.A) from Syracuse University.

Brownstone's innovative and solution-driven mindset has earned him remarkable success in new product creation, sales, development, and launch. He has increased annual sales by over $100 million on several brands, generating over $200 million incremental sales through the development of consumer OTC products at GlaxoSmithKline Consumer Healthcare Division. He has also created over $350 million incremental sales across a variety of CPG companies in the Food, Financial, Household, and Auto categories as a Partner at the Eureka Ranch Innovation company.

Brownstone's specialties include digital Consumer Package Goods (CPG) Marketing, Innovation, New Product Development, Customer Insights, Strategy Development, Market Research, Retail Experience, Advertising, Front End Innovation, Digital, Social Media, and Consulting. His leadership roles at GlaxoSmithKline, Samsung, Becton Dickinson, Novartis, Johnson & Johnson, and Procter & Gamble have helped him hone his expertise over time.

For instance, as the General Manager at Samsung Medical Device Division, he developed several new products for launch. At Novartis, he turned around the $100 million Maalox antacid business, growing market share for the first time in a decade despite the launch of new technology in the category (Prevacid, Tagamet, and Zantac). Brownstone's combination of digital marketing and innovation expertise has enabled him to build businesses with the right strategic focus consistently.